Literature DB >> 21302009

Prolonged intragastric drug delivery mediated by Eudragit® E-carrageenan polyelectrolyte matrix tablets.

Ahmad Bani-Jaber1, Leena Al-Aani, Hatim Alkhatib, Bashar Al-Khalidi.   

Abstract

Interpolyelectrolyte (IPE) complexation between carrageenan (CG) and Eudragit E (EE) was studied in 0.1 M HCl and was used to develop floating matrix tablets aimed to prolong gastric-residence time and sustain delivery of the loaded drug. The optimum EE/CG IPE complexation weight ratio (0.6) was determined in 0.1 M HCl using apparent viscosity measurements. The IPE complex was characterized by Fourier transform infrared spectroscopy and differential scanning calorimetry. Metronidazole matrix tablets were prepared by direct compression using EE, CG, or hybrid EE/CG with ratio optimal for IPE complexation. Corresponding effervescent tablets were prepared by including Na bicarbonate as an effervescent agent. Tablets were evaluated for in vitro buoyancy and drug release in 0.1 M HCl. Both CG and EE-CG effervescent matrices (1:2 drug to polymer weight ratio, 60 mg Na bicarbonate) achieved fast and prolonged floating with floating lag times less than 30 s and floating duration of more than 10 h. The corresponding EE effervescent matrices showed delayed floating and rapid drug release, and completely dissolved after 3 h of dissolution. CG matrices showed an initial burst drug release (48.3±5.0% at 1 h) followed by slow drug release over 8 h. EE-CG matrices exhibited sustained drug release in almost zero-order manner for 10 h (68.2±6.6%). The dissolution data of these matrices were fitted to different dissolution models. It was found that drug release followed zero-order kinetics and was controlled by the superposition of the diffusion and erosion.
© 2011 American Association of Pharmaceutical Scientists

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21302009      PMCID: PMC3066363          DOI: 10.1208/s12249-011-9595-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  18 in total

Review 1.  Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.

Authors:  B N Singh; K H Kim
Journal:  J Control Release       Date:  2000-02-03       Impact factor: 9.776

2.  pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery.

Authors:  M V Risbud; A A Hardikar; S V Bhat; R R Bhonde
Journal:  J Control Release       Date:  2000-07-31       Impact factor: 9.776

3.  Basic butylated methacrylate copolymer/kappa-carrageenan interpolyelectrolyte complex: preparation, characterization and drug release behaviour.

Authors:  H J Prado; M C Matulewicz; P Bonelli; A L Cukierman
Journal:  Eur J Pharm Biopharm       Date:  2008-04-29       Impact factor: 5.571

4.  Stability of metronidazole, tetracycline HCl and famotidine alone and in combination.

Authors:  Yunqi Wu; Reza Fassihi
Journal:  Int J Pharm       Date:  2005-01-12       Impact factor: 5.875

5.  The use of carrageenan in mixture with microcrystalline cellulose and its functionality for making tablets.

Authors:  K M Picker
Journal:  Eur J Pharm Biopharm       Date:  1999-07       Impact factor: 5.571

6.  Formulation and evaluation of famotidine floating tablets.

Authors:  M Jaimini; A C Rana; Y S Tanwar
Journal:  Curr Drug Deliv       Date:  2007-01       Impact factor: 2.565

7.  Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes.

Authors:  Rouslan I Moustafine; Igor M Zaharov; Vera A Kemenova
Journal:  Eur J Pharm Biopharm       Date:  2005-12-27       Impact factor: 5.571

8.  Characterization of a diltiazem-lambda carrageenan complex.

Authors:  M C Bonferoni; S Rossi; F Ferrari; G P Bettinetti; C Caramella
Journal:  Int J Pharm       Date:  2000-05-10       Impact factor: 5.875

9.  Effects of drying methods on the physicochemical and compressional characteristics of Okra powder and the release properties of its metronidazole tablet formulation.

Authors:  L G Bakre; K T Jaiyeoba
Journal:  Arch Pharm Res       Date:  2009-03-13       Impact factor: 4.946

10.  Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.

Authors:  Manoj N Gambhire; Kshitij W Ambade; Sushma D Kurmi; Vilasrao J Kadam; Kisan R Jadhav
Journal:  AAPS PharmSciTech       Date:  2007-09-07       Impact factor: 3.246

View more
  2 in total

1.  Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery.

Authors:  Balamurugan Jeganathan; Vijayalakshmi Prakya
Journal:  AAPS PharmSciTech       Date:  2015-01-16       Impact factor: 3.246

Review 2.  Marine algae sulfated polysaccharides for tissue engineering and drug delivery approaches.

Authors:  Tiago H Silva; Anabela Alves; Elena G Popa; Lara L Reys; Manuela E Gomes; Rui A Sousa; Simone S Silva; João F Mano; Rui L Reis
Journal:  Biomatter       Date:  2012 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.